Bridging the gap between islet allotransplantation and regulatory reform
Drug Discovery World
SEPTEMBER 26, 2024
This shift would not only streamline the transplantation process, but also ensure timely access to this critical therapy for those in need. Many patients and healthcare providers are still unaware of the potential benefits of this therapy. Rita Bottino leads Imagine Pharma’s Islet Programs.
Let's personalize your content